Jose Guillen Misses Out on Postseason Roster Due to Steroid Investigation
With the San Francisco Giants leading the World Series 2-0, rumors have begun to fly regarding one of the members of their team and his failure to make the post season roster. According to San Francisco Giants manager Bruce Bochy, Jose Guillen has been excluded from the post season roster due to neck injuries. On the other hand, speculation has swirled about the Giants holding Guillen from the post season roster due to an ongoing investigation linking Guillen to HGH shipments.
The whole story is fairly ironic due to the fact that the Giants were the team that was plagued by performance enhancing drug rumors, accusations, and the dark cloud of Barry Bonds. With the team on the brink of capturing its first World Series victory since 1954, performance enhancing drugs can stealing the spotlight. According to reports, federal authorities informed Major League Baseball there is an ongoing investigation involving Jose Guillen. Major League Baseball has also opened an investigation regarding Guillen and the shipments. Look for more details to emerge in the coming days. Guillen, a career .270 hitter with 214 HRS and 887 RBI's, has had an injury plagued career and anger management issues. At this point it is pure speculation, but so far in the age of performance enhancing drugs and HGH in baseball, where there is smoke, there is fire.
My name is Christopher Fusco. I am the managing partner of Callahan & Fusco, LLC with offices in New York, New Jersey, and Pennsylvania.